نتایج جستجو برای: آپولیپوپروتئین ε4

تعداد نتایج: 1371  

Journal: :JAMA neurology 2015
Allison R Kaup Jasmine Nettiksimmons Tamara B Harris Kaycee M Sink Suzanne Satterfield Andrea L Metti Hilsa N Ayonayon Kristine Yaffe

IMPORTANCE Apolipoprotein E (APOE) ε4 is an established risk factor for cognitive decline and the development of dementia, but other factors may help to minimize its effects. OBJECTIVE Using APOE ε4 as an indicator of high risk, we investigated factors associated with cognitive resilience among black and white older adults who are APOE ε4 carriers. DESIGN, SETTING, AND PARTICIPANTS Particip...

2015
Chunhua Yang Geng Tian Jia Mi Xiaodan Wei Xuri Li Xianglin Li Wenming Wang Bin Wang

We summarized published data on the associations of apolipoprotein E (APOE) gene ε2/ε3/ε4 polymorphism with both cancer risk and circulating lipid profiles, aiming to examine the causal relevance between lipids and cancer risk. Article identification and data abstraction were conducted in duplicate and independently by two authors. Data were analyzed by STATA software. Twenty-five articles that...

2011
Seiju Kobayashi Masaru Tateno Tae Woo Park Kumiko Utsumi Hitoshi Sohma Yoichi M. Ito Yasuo Kokai Toshikazu Saito

BACKGROUND The apolipoprotein E (APOE) ε4 allele has been reported to be a risk factor for Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). Previous neuropathological studies have demonstrated similar frequencies of the APOE ε4 allele in AD and DLB. However, the few ante-mortem studies on APOE allele frequencies in DLB have shown lower frequencies than post-mortem studies. One reas...

Journal: :Gene 2012
Yan-Wei Yin Yun-Dong Zhang Jing-Zhou Wang Bing-Hu Li Qing-Wu Yang Chuan-Qin Fang Chang-Yue Gao Jing-Cheng Li Li-Li Zhang

Epidemiological studies have evaluated the association between apolipoprotein E (ApoE) gene polymorphism and multiple sclerosis (MS) risk. However, the results remain conflicting. Therefore, in order to derive a more precise association of ApoE gene polymorphism with MS risk, we performed this meta-analysis. Systematic searches of electronic databases PubMed, Embase and Web of Science, as well ...

Journal: :JAMA neurology 2013
Hillary D Protas Kewei Chen Jessica B S Langbaum Adam S Fleisher Gene E Alexander Wendy Lee Daniel Bandy Mony J de Leon Lisa Mosconi Shannon Buckley Diana Truran-Sacrey Norbert Schuff Michael W Weiner Richard J Caselli Eric M Reiman

OBJECTIVE To characterize and compare measurements of the posterior cingulate glucose metabolism, the hippocampal glucose metabolism, and hippocampal volume so as to distinguish cognitively normal, late-middle-aged persons with 2, 1, or 0 copies of the apolipoprotein E (APOE) ε4 allele, reflecting 3 levels of risk for late-onset Alzheimer disease. DESIGN Cross-sectional comparison of measurem...

2015
Saeed Mohammad Al-Asmary Saeed Kadasah Misbahul Arfin Mohammad Tariq Abdulrahman Al-Asmari

INTRODUCTION Apolipoprotein E (APOE) genotypes influence the phenotype of several neurodegenerative disorders including Alzheimer's and Parkinson disease and may affect schizophrenia pathogenesis. This study was undertaken to determine the association between APOE gene polymorphisms and schizophrenia in the Saudi population. MATERIAL AND METHODS APOE allele and genotype frequencies were studi...

2012
Pei Xue Wen-Quan Niu Zhao-Yan Jiang Min-Hua Zheng Jian Fei

BACKGROUND Numerous studies have investigated the relationship between apolipoprotein (Apo) E gene polymorphisms and gallbladder stone disease (GSD) across ethnic populations; however, the results are often inconsistent. This meta-analysis aims to comprehensively evaluate the influence of a common ε2/ε3/ε4 polymorphism in Apo E gene on the risk of gallbladder stone disease. METHOD Data were a...

Journal: :Annals of neurology 2015
Katrine L Rasmussen Anne Tybjaerg-Hansen Børge G Nordestgaard Ruth Frikke-Schmidt

OBJECTIVE The apolipoprotein E (APOE) ε4 allele is a major genetic risk factor for Alzheimer disease and dementia. However, it remains unclear whether plasma levels of apoE confer additional risk. We tested this hypothesis. METHODS Using 75,708 participants from the general population, we tested whether low plasma levels of apoE at study enrollment were associated with increased risk of futur...

2017
Zuzana Nedelska Scott A. Przybelski Timothy G. Lesnick Christopher G. Schwarz Val J. Lowe Mary M. Machulda Walter K. Kremers Michelle M. Mielke Rosebud O. Roberts Bradley F. Boeve David S. Knopman Ronald C. Petersen Clifford R. Jack Kejal Kantarci

OBJECTIVE To assess whether noninvasive proton magnetic resonance spectroscopy (1H-MRS) tissue metabolite measurements at baseline can predict an increase in the rate of β-amyloid (Aβ) accumulation on serial PET in clinically normal (CN) older adults. METHODS Consecutive participants aged 60 years and older (n = 594) from the Mayo Clinic Study of Aging who were CN at baseline and who underwen...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید